5401 - 5425 of 9037 Results
Title
Year
- From Parkinson's Progression Markers Initiative to Parkinson's Precision Medicine Initiative: Still PPMI2026RESTRICTEDTitle: From Parkinson's Progression Markers Initiative to Parkinson's Precision Medicine Initiative: Still PPMIJournal Name: Annals of NeurologyPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.78242Citation Count: 0
- How to evaluate effects of occupational therapy – lessons learned from an exploratory randomized controlled trial2019RESTRICTEDTitle: How to evaluate effects of occupational therapy – lessons learned from an exploratory randomized controlled trialJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 67Issue #:Start Page: 42End Page: 47Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.09.013Citation Count: 4
-
OPENTitle: The effects of dopamine on digit span in Parkinson’s diseaseJournal Name: Journal of Clinical Movement DisordersPublisher: Springer Science and Business Media LLCVol: 3Issue #: 1Start Page: 5End Page: 5Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40734-016-0033-zBest OA location URL: https://clinicalmovementdisorders.biomedcentral.com/track/pdf/10.1186/s40734-016-0033-zCitation Count: 25
- Wearable Electrochemical Microneedle Sensor for Continuous Monitoring of Levodopa: Toward Parkinson Management2019RESTRICTEDTitle: Wearable Electrochemical Microneedle Sensor for Continuous Monitoring of Levodopa: Toward Parkinson ManagementJournal Name: ACS SensorsPublisher: American Chemical Society (ACS)Vol: 4Issue #: 8Start Page: 2196End Page: 2204Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acssensors.9b01127Citation Count: 349
- Combined fenobam and amantadine treatment promotes robust antidyskinetic effects in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐lesioned primate model of Parkinson's disease2014RESTRICTEDTitle: Combined fenobam and amantadine treatment promotes robust antidyskinetic effects in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐lesioned primate model of Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 29Issue #: 6Start Page: 772End Page: 779Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.25859Citation Count: 40
-
OPENTitle: Best Practices for Generating and Using Alpha-Synuclein Pre-Formed Fibrils to Model Parkinson’s Disease in RodentsJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 8Issue #: 2Start Page: 303End Page: 322Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-171248Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd171248?id=journal-of-parkinsons-disease%2Fjpd171248Citation Count: 299
-
OPENTitle: Systematic proteomic analysis of LRRK2-mediated Rab GTPase phosphorylation establishes a connection to ciliogenesisJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 6Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.31012Best OA location URL: https://doi.org/10.7554/elife.31012Citation Count: 504
- Patient-Centered Clinical Trial Design: A Case Study in Parkinson’s Disease (P2.8-008)2019RESTRICTEDTitle: Patient-Centered Clinical Trial Design: A Case Study in Parkinson’s Disease (P2.8-008)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 92Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p2.8-008Citation Count: 0
- Differential effects of goal cues on everyday action errors in Alzheimer’s disease versus Parkinson’s disease dementia.2014RESTRICTEDTitle: Differential effects of goal cues on everyday action errors in Alzheimer’s disease versus Parkinson’s disease dementia.Journal Name: NeuropsychologyPublisher: American Psychological Association (APA)Vol: 29Issue #: 4Start Page: 592End Page: 602Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1037/neu0000167Citation Count: 25
-
OPENTitle: Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH‐EXAMINER as a potential clinical trial endpointJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 16Issue #: 1Start Page: 11End Page: 21Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.jalz.2019.01.012Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.jalz.2019.01.012Citation Count: 51
- Brain activation pattern related to gait disturbances in Parkinson's disease2012RESTRICTEDTitle: Brain activation pattern related to gait disturbances in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 27Issue #: 12Start Page: 1498End Page: 1505Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.25139Citation Count: 53
-
OPENTitle: β-catenin aggregation in models of ALS motor neurons: GSK3β inhibition effect and neuronal differentiationJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 130Issue #:Start Page: 104497End Page: 104497Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.nbd.2019.104497Best OA location URL: https://repositorio.uchile.cl/handle/2250/172258Citation Count: 25
- TC-8831, a nicotinic acetylcholine receptor agonist, reduces l-DOPA-induced dyskinesia in the MPTP macaque2013RESTRICTEDTitle: TC-8831, a nicotinic acetylcholine receptor agonist, reduces l-DOPA-induced dyskinesia in the MPTP macaqueJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 73Issue #:Start Page: 337End Page: 347Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2013.06.005Citation Count: 38
-
OPENTitle: Structure-guided Discovery of Non-catechol Dopamine D1 Receptor Ligands with Biased Agonism and AntagonismJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 302Issue #: 6Start Page: 113076End Page: 113076Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jbc.2026.113076Best OA location URL: https://www.jbc.org/article/S0021-9258(26)01948-4/pdfCitation Count: 0
-
OPENTitle: α‐Synuclein Pathology in PRKN‐Linked Parkinson's Disease: New Insights from a Blood‐Based Seed Amplification AssayJournal Name: Annals of NeurologyPublisher: WileyVol: 95Issue #: 6Start Page: 1173End Page: 1177Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/ana.26917Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.26917Citation Count: 28
-
OPENTitle: Impact of antibiotics on smell dysfunctionJournal Name: World Journal of Otorhinolaryngology - Head and Neck SurgeryPublisher: WileyVol: 4Issue #: 1Start Page: 33End Page: 38Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.wjorl.2018.03.002Best OA location URL: https://www.sciencedirect.com/science/article/pii/S2095881118300210?via%3DihubCitation Count: 15
-
OPENTitle: Mining the neuroimaging literatureJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.94909.2Best OA location URL: https://doi.org/10.7554/elife.94909.2Citation Count: 0
-
OPENTitle: LRRK2-phosphorylated Rab10 sequesters Myosin Va with RILPL2 during ciliogenesis blockadeJournal Name: Life Science AlliancePublisher: Life Science Alliance, LLCVol: 4Issue #: 5Start Page: e202101050End Page: e202101050Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.26508/lsa.202101050Best OA location URL: https://www.life-science-alliance.org/content/lsa/4/5/e202101050.full.pdfCitation Count: 54
- Anxiety and motor fluctuations in Parkinson's disease: A cross-sectional observational study2012RESTRICTEDTitle: Anxiety and motor fluctuations in Parkinson's disease: A cross-sectional observational studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 18Issue #: 10Start Page: 1084End Page: 1088Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2012.06.007Citation Count: 93
-
OPENTitle: Distinct AQP4 Alterations in Movement Disorders with Primary SynucleinopathyJournal Name: Movement DisordersPublisher: WileyVol: 40Issue #: 12Start Page: 2804End Page: 2810Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.70023Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.70023Citation Count: 5
-
OPENTitle: Bradykinesia and Its Progression Are Related to Interhemispheric Beta CoherenceJournal Name: Annals of NeurologyPublisher: WileyVol: 93Issue #: 5Start Page: 1029End Page: 1039Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.26605Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10191890/pdf/nihms-1865546.pdfCitation Count: 22
- Tissue transglutaminase in Alzheimer's disease – facts and fiction: a reply to “Tissue transglutaminase is a biochemical marker for Alzheimer's disease”2013RESTRICTEDTitle: Tissue transglutaminase in Alzheimer's disease – facts and fiction: a reply to “Tissue transglutaminase is a biochemical marker for Alzheimer's disease”Journal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 35Issue #: 4Start Page: e5End Page: e9Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2013.09.042Citation Count: 14
- Expert comment to: Novel Xp21.1 deletion associated with unusual features in large McLeod syndrome kindred2019RESTRICTEDTitle: Expert comment to: Novel Xp21.1 deletion associated with unusual features in large McLeod syndrome kindredJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 79Issue #:Start Page: 133End Page: 134Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.024Citation Count: 2
-
OPENTitle: Cortico-cortical paired associative stimulation increases SMA-M1 facilitation in tremor-dominant Parkinson’s diseaseJournal Name: Clinical NeurophysiologyPublisher: Elsevier BVVol: 188Issue #:Start Page: 2111928End Page: 2111928Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.clinph.2026.2111928Best OA location URL: https://doi.org/10.1016/j.clinph.2026.2111928Citation Count: 0
-
OPENTitle: Plasma Phosphorylated Tau181 as a Biomarker for Alzheimer's Disease Co‐Pathology in Lewy Body DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 40Issue #: 9Start Page: 1930End Page: 1939Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.30238Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC12254929/Citation Count: 2